Impact of fasting glycemia on short-term prognosis after acute myocardial infarction

Journal of Clinical Endocrinology and Metabolism

Volumn 92, Issue 6, 2007, Pages 2136-2140

  Vergès, Bruno ^a   Zeller, Marianne ^b   Dentan, Gilles ^c   Beer, Jean Claude ^a   Laurent, Yves ^d   Janin Manificat, Luc ^d   Makki, Hamid ^d   Wolf, Jean Eric ^a   Cottin, Yves ^a  

^a HÔPITAL DU BOCAGE   (France)

^b UNIVERSITÉ DE BOURGOGNE   (France)

^c Clinique de Fontaine   (France)

^d CENTRE HOSPITALIER   (France)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE;

ACUTE HEART INFARCTION; ADULT; AGED; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIABETES MELLITUS; DIET RESTRICTION; FEMALE; GLUCOSE BLOOD LEVEL; HEART FAILURE; HUMAN; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RECEIVER OPERATING CHARACTERISTIC; SURVIVAL;

EID: 34347210710     PISSN: 0021972X     EISSN: 0021972X     Source Type: Journal    
DOI: 10.1210/jc.2006-2584     Document Type: Article

References (32)

1. Abbud ZA, Shindler DM, Wilson AC, Kostis JB 1995 Effect of diabetes mellitus on short- and long-term mortality rates of patients with acute myocardial infarction: a statewide study. Myocardial Infarction Data Acquisition System Study Group. Am Heart J 130:51-58
2. Franklin K, Goldberg RJ, Spencer F, Klein W, Budaj A, Brieger D, Marre M, Steg PG, Gowda N, Gore JM 2004 GRACE Investigators. Implications of diabetes in patients with acute coronary syndromes. The Global Registry of Acute Coronary Events. Arch Intern Med 164:1457-1463
3. Zeller M, Cottin Y, Brindisi MC, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Beer JC, Touzery C, Makki H, Verges B, Wolf JE 2004 The RICO survey working group. Impaired fasting glucose and cardiogenic shock in patients with acute myocardial infarction. Eur Heart J 25:308-312
4. Expert Committee on the Diagnosis and Classification 1997 Report of the Expert Committee on the Diagnosis and Classification of Diabetes Mellitus. Diabetes Care 20:1183-1197
5. American Diabetes Association 2004 Screening for type 2 diabetes. Diabetes Care 27:S11-S14
6. Vergès B, Zeller M, Desgres J, Dentan G, Laurent Y, Janin-Manificat L, L'Huillier I, Rioufol G, Beer JC, Makki H, Rochette L, Gambert P, Cottin Y 2005 High plasma N-terminal pro-brain natriuretic peptide level found in diabetic patients after myocardial infarction is associated with an increased risk of in-hospital mortality and cardiogenic shock. Eur Heart J 26:1734-1741
7. Alpert JS, Thygesen K, Antman E, Bassand JP 2000 Myocardial infarction redefined - a consensus document of the Joint European Society of Cardiology/ American College of Cardiology Committee for the Redefinition of Myocardial Infarction. J Am Coll Cardiol 36:959-969
8. Norhammar A, Tenerz A, Nilsson G, Hamsten A, Efendic S, Ryden L, Malmberg K 2002 Glucose metabolism in patients with acute myocardial infarction and no previous diagnosis of diabetes mellitus: a prospective study. Lancet 359:2140-2144
9. Friedewald WT, Levy RI, Fredrickson DS 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 18:499-502
10. Hasdai D, Califf RM, Thompson TD, Hochman JS, Ohman EM, Pfisterer M, Bates ER, Vahanian A, Armstrong PW, Criger DA, Topol EJ, Holmes Jr DR 2000 Predictors of cardiogenic shock after thrombolytic therapy for acute myocardial infarction. J Am Coll Cardiol 35:136-143
11. Suleiman M, Hammerman H, Boulos M, Kapeliovich MR, Suleiman A, Agmon Y, Markiewicz W, Aronson D 2005 Fasting glucose is an important independent risk factor for 30-day mortality in patients with acute myocardial infarction: a prospective study. Circulation 111:754-760
12. Hanley JA, McNeil BJ 1983 A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology 148: 839-843
13. Malmberg K, Ryden L, Wedel H, Birkeland K, Bootsma A, Dickstein K, Efendic S, Fisher M, Hamsten A, Herlitz J, Hildebrandt P, MacLeod K, Laakso M, Torp-Pedersen C, Waldenstrom A 2005 DIGAMI 2 Investigators. Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity. Eur Heart J 26:650-661
14. Muhlestein JB, Anderson JL, Horne BD, Lavasani F, Allen Maycock CA, Bair TL, Pearson RR, Carlquist JF Intermountain Heart Collaborative Study Group. Effect of fasting glucose levels on mortality rate in patients with and without diabetes mellitus and coronary artery disease undergoing percutaneous coronary intervention. Am Heart J 146:351-358
15. Bartnik M, Ryden L, Ferrari R, Malmberg K, Pyorala K, Simoons M, Standl R, Soler-Soler J, Ohrvik J 2004 Euro Heart Survey Investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 25:1880-1890
16. Oswald GA, Smith CC, Betteridge DJ, Yudkin JS 1986 Determinants and importance of stress hyperglycaemia in non-diabetic patients with myocardial infarction. Br Med J (Clin Res Ed) 293:917-922
17. Bellodi G, Manicardi V, Malavasi V, Veneri L, Bernini G, Bossini P, Distefano S, Magnanini G, Muratori L, Rossi G, Zuarini A 1989 Hyperglycemia and prognosis of acute myocardial infarction in patients without diabetes mellitus. Am J Cardiol 64:885-888
18. Foo K, Cooper J, Deaner A, Knight C, Suliman A, Ranjadayalan K, Timmis AD 2003 A single serum glucose measurement predicts adverse outcomes across the whole range of acute coronary syndromes. Heart 89:512-516
19. Capes SE, Hunt D, Malmberg K, Gerstein HC 2000 Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet 355:773-778
20. Ishihara M, Inoue I, Kawagoe T, Shimatani Y, Kurisu S, Hata T, Nakama Y, Kijima Y, Kagawa E 2006 Is admission hyperglycaemia in non-diabetic patients with acute myocardial infarction a surrogate for previously undiagnosed abnormal glucose tolerance? Eur Heart J 27:2413-2419
21. Ravid M, Berkowicz M, Sohar E 1975 Hyperglycemia during acute myocardial infarction. A six-year follow-up study. JAMA 233:807-809
22. O'Sullivan JJ, Conroy RM, Robinson K, Hickey N, Mulcahy R 1991 Inhospital prognosis of patients with fasting hyperglycemia after first myocardial infarction. Diabetes Care 14:758-760
23. Tai ES, Goh SY, Lee JJ, Wong MS, Heng D, Hughes K, Chew SK, Cutter J, Chew W, Gu K, Chia KS, Tan CE 2004 Lowering the criterion for impaired fasting glucose: impact on disease prevalence and associated risk of diabetes and ischemic heart disease. Diabetes Care 27:1728-1734
24. Schriger DL, Lorber B 2004 Lowering the cut point for impaired fasting glucose: where is the evidence? Where is the logic? Diabetes Care 27:592-601
25. Kim SH, Chunawala L, Linde R, Reaven GM 2006 Comparison of the 1997 and 2003 American Diabetes Association Classification of Impaired Fasting Glucose. J Am Coll Cardiol 48:293-297
26. Devos P, Chiolero R, Van den Berghe G, Preiser JC 2006 Glucose, insulin and myocardial ischaemia. Curr Opin Clin Nutr Metab Care 9:131-139
27. Ren J, Gintant GA, Miller RE, Davidoff AJ 1997 High extracellular glucose impairs cardiac E-C coupling in a glycosylation-dependent manner. Am J Physiol 273:H2876-H2883
28. Oliver MF, Opie LH 1994 Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet 343:155-158
29. Marfella R, Siniscalchi M, Esposito K, Sellitto A, De Fanis U, Romano C, Portoghese M, Siciliano S, Nappo F, Sasso FC, Mininni N, Cacciapuoti F, Lucivero G, Giunta R, Verza M, Giugliano D 2003 Effects of stress hyperglycemia on acute myocardial infarction: role of inflammatory immune process in functional cardiac outcome. Diabetes Care 26:3129-3135
30. Iwakura K, Ito H, Ikushima M, Kawano S, Okamura A, Asano K, Kuroda T, Tanaka K, Masuyama T, Hori M, Fujii K 2003 Association between hyperglycemia and the no-reflow phenomenon in patients with acute myocardial infarction. J Am Coll Cardiol 41:1-7
31. Timmer JR, Ottervanger JP, de Boer MJ, Dambrink JH, Hoorntje JC, Gosselink AT, Suryapranata H, Zijlstra F, van't Hof AW 2005 Zwolle Myocardial Infarction Study Group. Hyperglycemia is an important predictor of impaired coronary flow before reperfusion therapy in ST-segment elevation myocardial infarction. J Am Coll Cardiol 45:999-1002
32. Van den Berghe G, Wouters P, Weekers F, Verwaest C, Bruyninckx F, Schetz M, Vlasselaers D, Ferdinande P, Lauwers P, Bouillon R 2001 Intensive insulin therapy in the critically ill patients. N Engl J Med 345:1359-1367